by [150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global diagnostic testing market was valued at around USD 165.58 billion in 2021 and is expected to register revenues worth USD 348.75 billion by the end of 2030, growing at an exceptional CAGR of approximately 8.63% between 2022 and 2030.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1984
Diagnostic Testing Market Report Scope
A recent study by Precedence Research on the diagnostic testing market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the diagnostic testing market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of diagnostic testing. The study also provides the dynamics that are responsible for influencing the future status of the diagnostic testing market over the forecast period.
A detailed assessment of the diagnostic testing market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the diagnostic testing market along with their product portfolio enhances the reliability of this comprehensive research study.
Competition Landscape
The report has engulfed a chapter on the global diagnostic testing market’s competitive landscape, which provides detailed analysis and insights on companies offering diagnostic testing. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.
This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.
Read Also@ Artificial Intelligence in Transportation Market Size to Worth Around US$ 14.79 Billion by 2030
Some of the Prominent Players in the Diagnostic Testing Market Include:
- F-Hoffman La-Rcohe Ltd. (Switzerland)
- Danaher (US)
- BD (US)
- Thermo Fisher Scientific Inc. (US)
- ACON Laboratories Inc. (US)
- Hemosure, Inc. (US)
- MicroGen Diagnostics (US)
- Grifols, S.A (Spain)
- BODITECH MED INC. (South Korea)
- Chembio Diagnostic Systems, Inc. (US)
- Nanoentek (South Korea)
- DiaSorin S.p.A. (Italy)
- Bio-Rad Laboratories, Inc. (US)
- BIOMEDOMICS INC (US)
- EKF Diagnostics Holdings plc (UK)
- Siemens Healthcare GmbH (Germany)
- PerkinElmer Inc. (US)
- bioMérieux SA (France)
- ARKRAY USA, Inc. (US)
- Biohit Oyj (Finland)
- Quidel Corporation (US)
- Illumina, Inc. (US)
- Lamdagen Corporation (US)
- LifeSign LLC. (US)
- Medixbiochemica (Finaland)
- Nova Biomedical (US)
- Ortho Clinical Diagnostics (US)
- Sannuo Biosensing Co., Ltd. (US)
- STRECK (US)
- Sysmex Corporation (Japan)
Diagnostic Testing Market Segmentation
By Type
- Clinical Diagnostic
- Home Diagnostic
By Application
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Odontology
- Others
By Approach
- Molecular Diagnostic Instrument
- In-Vitro Diagnostic Instrument
- Point Of Care Testing Instrument
By Solution
- Services
- Products
By Technology
- Immunoassay-Based
- PCR-Based
- Next-generation Sequencing
- Spectroscopy-Based
- Chromatography-Based
- Microfluidics
- Substrate Technology
- Others
By Mode of Testing
- Prescription Based Testing
- OTC Testing
By Sample Type
- Urine
- Saliva
- Blood
- Hair
- Sweat
- Others
By Testing Type
- Biochemistry
- Hematology
- Microbiology
- Histopathology
- Others
By Age
- Pediatric
- Adult & Geriatric
By Distribution Channel
- Direct Tenders
- Retail Sales
- Online Sales
By End User
- Hospitals, Diagnostic Center
- Research Labs and Institutes
- Research Institute
- Homecare
- Blood Banks
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global diagnostic testing market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the diagnostic testing market.
The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.
Why should you invest in this report?
If you are aiming to enter the global diagnostic testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for diagnostic testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Ages
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Eleven Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diagnostic Testing Market, By Type
7.1. Diagnostic Testing Market, by Type, 2022-2030
7.1.1. Clinical Diagnostic
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Home Diagnostic
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Diagnostic Testing Market, By Application
8.1. Diagnostic Testing Market, by Application, 2022-2030
8.1.1. Cardiology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Oncology
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Neurology
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Orthopedics
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Gastroenterology
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Gynecology
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Odontology
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Diagnostic Testing Market, By Approach
9.1. Diagnostic Testing Market, by Approach, 2022-2030
9.1.1. Molecular Diagnostic Instrument
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. In-Vitro Diagnostic Instrument
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Point Of Care Testing Instrument
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Diagnostic Testing Market, By Solution
10.1. Diagnostic Testing Market, by Solution, 2022-2030
10.1.1. Services
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Products
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Diagnostic Testing Market, By Technology
11.1. Diagnostic Testing Market, by Technology, 2022-2030
11.1.1. Immunoassay-Based
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. PCR-Based
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Next-generation Sequencing
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Spectroscopy-Based
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Chromatography-Based
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Microfluidics
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Substrate Technology
11.1.7.1. Market Revenue and Forecast (2017-2030)
11.1.8. Others
11.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Diagnostic Testing Market, By Mode of Testing
12.1. Diagnostic Testing Market, by Mode of Testing, 2022-2030
12.1.1. Prescription Based Testing
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. OTC Testing
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Diagnostic Testing Market, By Sample Type
13.1. Diagnostic Testing Market, by Sample Type, 2022-2030
13.1.1. Urine
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Saliva
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Blood
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Hair
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Sweat
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Others
13.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Diagnostic Testing Market, By Testing Type
14.1. Diagnostic Testing Market, by Testing Type, 2022-2030
14.1.1. Biochemistry
14.1.1.1. Market Revenue and Forecast (2017-2030)
14.1.2. Hematology
14.1.2.1. Market Revenue and Forecast (2017-2030)
14.1.3. Microbiology
14.1.3.1. Market Revenue and Forecast (2017-2030)
14.1.4. Histopathology
14.1.4.1. Market Revenue and Forecast (2017-2030)
14.1.5. Others
14.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 15. Global Diagnostic Testing Market, By Age
15.1. Diagnostic Testing Market, by Age, 2022-2030
15.1.1. Pediatric
15.1.1.1. Market Revenue and Forecast (2017-2030)
15.1.2. Adult & Geriatric
15.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 16. Global Diagnostic Testing Market, By Distribution Channel
16.1. Diagnostic Testing Market, by Distribution Channel, 2022-2030
16.1.1. Direct Tenders
16.1.1.1. Market Revenue and Forecast (2017-2030)
16.1.2. Retail Sales
16.1.2.1. Market Revenue and Forecast (2017-2030)
16.1.3. Online Sales
16.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 17. Global Diagnostic Testing Market, By End User
17.1. Diagnostic Testing Market, by End User, 2022-2030
17.1.1. Hospitals, Diagnostic Center
17.1.1.1. Market Revenue and Forecast (2017-2030)
17.1.2. Research Labs and Institutes
17.1.2.1. Market Revenue and Forecast (2017-2030)
17.1.3. Research Institute
17.1.3.1. Market Revenue and Forecast (2017-2030)
17.1.4. Homecare
17.1.4.1. Market Revenue and Forecast (2017-2030)
17.1.5. Blood Banks
17.1.5.1. Market Revenue and Forecast (2017-2030)
17.1.6. Specialty Clinics
17.1.6.1. Market Revenue and Forecast (2017-2030)
17.1.7. Ambulatory Surgical Centers
17.1.7.1. Market Revenue and Forecast (2017-2030)
17.1.8. Others
17.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 18. Global Diagnostic Testing Market, Regional Estimates and Trend Forecast
18.1. North America
18.1.1. Market Revenue and Forecast, by Type (2017-2030)
18.1.2. Market Revenue and Forecast, by Application (2017-2030)
18.1.3. Market Revenue and Forecast, by Approach (2017-2030)
18.1.4. Market Revenue and Forecast, by Solution (2017-2030)
18.1.5. Market Revenue and Forecast, by Technology (2017-2030)
18.1.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.1.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.1.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.1.9. Market Revenue and Forecast, by Age (2017-2030)
18.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.1.11. Market Revenue and Forecast, by End User (2017-2030)
18.1.12. U.S.
18.1.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.1.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.1.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.1.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.1.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.1.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.1.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.1.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.1.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.1.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.1.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.1.12.12. Market Revenue and Forecast, by December (2017-2030)
18.1.12.13. Market Revenue and Forecast, by Eleven (2017-2030)
18.1.13. Rest of North America
18.1.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.1.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.1.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.1.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.1.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.1.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.1.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.1.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.1.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.1.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.1.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.2. Europe
18.2.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.12. UK
18.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.13. Germany
18.2.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.14. France
18.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.14.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.14.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.14.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.14.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.14.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.14.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.15. Rest of Europe
18.2.15.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.15.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.15.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.15.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.15.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.15.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.15.11. Market Revenue and Forecast, by End User (2017-2030)
18.3. APAC
18.3.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.12. India
18.3.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.13. China
18.3.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.14. Japan
18.3.14.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.14.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.14.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.14.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.14.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.14.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.14.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.15. Rest of APAC
18.3.15.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.15.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.15.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.15.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.15.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.15.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.15.11. Market Revenue and Forecast, by End User (2017-2030)
18.4. MEA
18.4.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.12. GCC
18.4.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.13. North Africa
18.4.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.14. South Africa
18.4.14.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.14.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.14.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.14.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.14.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.14.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.14.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.15. Rest of MEA
18.4.15.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.15.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.15.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.15.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.15.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.15.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.15.11. Market Revenue and Forecast, by End User (2017-2030)
18.5. Latin America
18.5.1. Market Revenue and Forecast, by Type (2017-2030)
18.5.2. Market Revenue and Forecast, by Application (2017-2030)
18.5.3. Market Revenue and Forecast, by Approach (2017-2030)
18.5.4. Market Revenue and Forecast, by Solution (2017-2030)
18.5.5. Market Revenue and Forecast, by Technology (2017-2030)
18.5.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.5.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.5.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.5.9. Market Revenue and Forecast, by Age (2017-2030)
18.5.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.5.11. Market Revenue and Forecast, by End User (2017-2030)
18.5.12. Brazil
18.5.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.5.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.5.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.5.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.5.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.5.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.5.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.5.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.5.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.5.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.5.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.5.13. Rest of LATAM
18.5.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.5.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.5.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.5.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.5.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.5.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.5.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.5.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.5.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.5.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.5.13.11. Market Revenue and Forecast, by End User (2017-2030)
Chapter 19. Company Profiles
19.1. F-Hoffman La-Rcohe Ltd. (Switzerland)
19.1.1. Company Overview
19.1.2. Product Offerings
19.1.3. Financial Performance
19.1.4. Recent Initiatives
19.2. Danaher (US)
19.2.1. Company Overview
19.2.2. Product Offerings
19.2.3. Financial Performance
19.2.4. Recent Initiatives
19.3. BD (US)
19.3.1. Company Overview
19.3.2. Product Offerings
19.3.3. Financial Performance
19.3.4. Recent Initiatives
19.4. Thermo Fisher Scientific Inc. (US)
19.4.1. Company Overview
19.4.2. Product Offerings
19.4.3. Financial Performance
19.4.4. Recent Initiatives
19.5. ACON Laboratories Inc. (US)
19.5.1. Company Overview
19.5.2. Product Offerings
19.5.3. Financial Performance
19.5.4. Recent Initiatives
19.6. Hemosure, Inc. (US)
19.6.1. Company Overview
19.6.2. Product Offerings
19.6.3. Financial Performance
19.6.4. Recent Initiatives
19.7. MicroGen Diagnostics (US)
19.7.1. Company Overview
19.7.2. Product Offerings
19.7.3. Financial Performance
19.7.4. Recent Initiatives
19.8. Grifols, S.A (Spain)
19.8.1. Company Overview
19.8.2. Product Offerings
19.8.3. Financial Performance
19.8.4. Recent Initiatives
19.9. BODITECH MED INC. (South Korea)
19.9.1. Company Overview
19.9.2. Product Offerings
19.9.3. Financial Performance
19.9.4. Recent Initiatives
19.10. Chembio Diagnostic Systems, Inc. (US)
19.10.1. Company Overview
19.10.2. Product Offerings
19.10.3. Financial Performance
19.10.4. Recent Initiatives
Chapter 20. Research Methodology
20.1. Primary Research
20.2. Secondary Research
20.3. Assumptions
Chapter 21. Appendix
21.1. About Us
21.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1984
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
